Monitoring Viral Suppression when switching from fixed dose combination efavirenz, emtricitabine and tenofovir (Atripla) to fixed dose combination elvitegravir, cobicistat, emtricitabine, and tenofovir (Stribild) in virologically suppressed adults with HIV